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Abstract 1
We have previously developed a novel in vitro assay that utilises cultures of primed female 2
stickleback kidney cells for the screening of potential androgenic and anti-androgenic 3
environmental contaminants. Stickleback kidney cells are natural targets for steroid hormones 4
and are able to produce a protein, spiggin, in response to androgenic stimulation. We 5
undertook a combined in vivo/in vitro study where we used the magnitude of spiggin 6
production as an endpoint to test the anti-androgenic properties of the pharmaceutical 7
androgen antagonist flutamide and three environmental contaminants: the organophosphate 8
insecticide fenitrothion, the urea-based herbicide linuron and the fungicide vinclozolin. In 9
vitro, kidney cells were exposed to a range of concentrations [from 10-14M (2.5pg/L) up to 10-10
6M (280µg/L)] of the test compounds alone for determining agonist activities, or together with 11
10-8M (3µg/L) dihydrotestosterone (DHT) for determining antagonist activities. An in vivo12
flow-trough aquarium-based study was carried out in parallel. Female sticklebacks were 13
exposed to a range of concentrations of the same chemicals alone or in combination with 14
DHT (5µg/L) for 21 days. All of the compounds significantly inhibited DHT-induced spiggin 15
production in a concentration-dependent manner in both the in vitro (FN≥FL≥LN>VZ) and in 16
vivo (FN>FL≥VZ>LN) assays. Fenitrothion and flutamide inhibited spiggin production in 17
vitro at a concentration as low as 10-12M (P<0.05), while linuron and vinclozolin inhibited 18
DHT-induced spiggin production at concentrations of 10-10M (P<0.05) and 10-6M (P<0.001) 19
respectively. Similarly, fenitrothion and flutamide were the most potent chemicals in vivo and 20
significantly reduced DHT-induced spiggin production at a concentration of 10µg/L and 21
25µg/L respectively (P<0.01). Both linuron and vinclozolin induced a significant decrease in 22
DHT-induced spiggin production at a concentration of 100µg/L when tested in vivo. In 23
addition, kidney cell primary culture was used to test the (anti-)androgenic effects of the 24
major environmental contaminants: oestradiol (E2), nonylphenol (NP) and bisphenol A 25
(BPA) for the first time in teleosts. We observed that these compounds were able to 26
significantly inhibit spiggin production at high doses (E2: 270µg/L; NP: 2.2µg/L; BPA: 27
2.3µg/L). When tested in the absence of DHT, none of the compounds showed a significant 28
agonistic activity in either in vivo or in vitro assays. Overall, our data further demonstrate that 29
kidney cell primary culture is a reliable and a sensitive screening tool for the detection of 30
(anti-)androgenic compounds. In addition, our study represents the first attempt to develop a 31
combined in vivo/in vitro screening strategy for assessing the effects of (anti-)androgenic 32
endocrine disrupters.33
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Introduction1
During the past decade an increasing incidence of reproductive disorders has been reported in 2
several animal taxa including humans. An increasing number of field and laboratory studies 3
have investigated the putative links between these disorders and the presence in the 4
environment of anthropogenic chemicals that are able to interfere with the endocrine 5
functions in both humans (Toppari et al., 1996; Sharpe and Skakkebaek, 2003) and wildlife 6
(Tyler et al., 1998; Vos et al., 2000). 7
Of particular concern are the chemicals that are able to mimic or block the responses typically 8
induced by male sexual hormones, the androgens. Indeed, early studies reported that a number 9
of environmental contaminants, including chemicals previously described as oestrogenic can 10
also act as anti-androgens (Eil and Nisula, 1990; Hose an Guillette, 1995; Kelce et al., 1995; 11
Kelce and Wilson 1997; Sohoni and Sumpter, 1998). In particular, there are data available 12
suggesting that several classes of pesticides are able to interfere with androgen functions and 13
can cause severe impairment in male sexual development and reproduction (Kelce et al., 14
1995; Kelce et al., 1997; Makynen et al., 2000; Sohoni et al., 2001). Humans are potentially 15
exposed to pesticides either directly, as workers in green-houses and in agriculture, or 16
indirectly, via food consumption. In addition, it is likely that a significant amount of these 17
pesticides and their metabolites reach rivers and estuaries via run-off from farmland thus 18
creating localised “hot-spots” of chemicals discharges that are potentially toxic to wildlife. 19
Despite these observations, most studies on aquatic species have focussed on the effects of 20
oestrogenic environmental contaminants (Jobling et al., 1995; Toppari et al., 1996; Sumpter et 21
al., 1996), while the potential effects of (anti-)androgenic chemicals on sexual development 22
and maturation in both human and wildlife have been somewhat overlooked. In teleosts as in 23
mammals, androgens are essential as they control male sexual differentiation and maturation 24
(Borg, 1994). They act by binding to specific intracellular androgen receptors (AR) to activate 25
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or repress the expression of specific genes, notably those involved in the development of male 1
primary and secondary sexual characters (reviewed by Delvin and Nagahama, 2002). It has 2
been shown that most of the (anti-)androgenic environmental contaminants are able to 3
interfere with the androgen signalling pathways by binding directly to the AR and act as 4
agonists or antagonists (Kelce et al., 1997; Wong et al., 1995).5
The screening and classification of endocrine disrupting chemicals (EDCs) are prerequisites 6
for identifying their potential to cause adverse effects on whole organisms. For this reason we 7
established a sensitive in vitro assay for the rapid screening of androgenic and anti-androgenic 8
chemicals (Jolly et al., 2006). Our method uses a three-spined stickleback (Gasterosteus 9
aculeatus) kidney cell primary culture and detects of spiggin production, an androgen induced 10
protein. The ability of stickleback kidney cells to produce spiggin in response to androgenic 11
stimulation has been extensively studied and is well documented. Under natural conditions, 12
this protein is only secreted during the breeding season by male sticklebacks that use it as glue 13
to build a nest (De Ruiter and Mein, 1982; Borg et al., 1993; Jakobsson et al., 1999; Jones et 14
al., 2001). However, Katsiadaki et al., (2002; 2006) showed that spiggin can be artificially 15
induced in female sticklebacks exposed to the androgens 17α-Methyltestosterone (MT) or 5α-16
Dihydrotestosterone (DHT) and that this induction was inhibited by flutamide, the synthetic 17
AR antagonist used in prostate cancer treatment. The expression of this male secondary 18
sexual character in female has been used as a biomarker for in vivo screening of (anti-19
)androgenic environmental contaminants (Katsiadaki et al, 2006). In a previous study, we 20
demonstrated that similar results can be obtained in vitro: both DHT and the teleost specific 21
androgen 11-ketotestosterone (11KT) induced spiggin production in kidney cells primary 22
culture, a stimulating effect that was significantly inhibited by co-treatment with flutamide23
(Jolly et al., 2006). 24
Page 6 of 50
Ac
ce
pte
d M
an
us
cri
pt
6
In the present study we tested the ability of three selected pesticides, fenitrothion, linuron and 1
vinclozolin, to inhibit DHT-induced spiggin production in stickleback kidney cell primary 2
culture. Fenitrothion, an organophosphate insecticide that represents one of the most widely 3
used classes of pesticides and linuron, a selective urea-based herbicide, are used for crop 4
protection. Vinclozolin is a fungicide widely used to control a variety of pathogens on fruit 5
and vegetables and for crop protection. The pharmacokinetics of endocrine disrupting 6
chemicals in vivo and their ability to interfere with multiple endocrine functions in a whole 7
organism emphasises the need to demonstrate that the proposed mechanisms of action 8
identified in vitro are also operative in vivo. In order to assess the degree to which results 9
obtained with kidney cell primary culture are predictive of the sticklebacks’ in vivo response, 10
we exposed female adult fish to DHT (5µg/L) alone or in combination with a range of 11
concentrations of the same test compounds (fenitrothion, linuron, vinclozolin or flutamide).12
Kidney cell primary culture was then used to assess, for the first time in teleosts, the (anti-13
)androgenic properties of two xenoestrogenic chemicals: nonylphenol (NP) and bisphenol A 14
(BPA). It was the first time this procedure has been undertaken in teleosts. NP is one of the 15
main degradation product of alkylphenol ethoxylate a class of chemicals used in several 16
industrial, agricultural and domestic applications including detergent and pesticides (Jobling 17
et al., 1996). BPA is a major component of consumer products such as polycarbonate plastics, 18
epoxy resins, and flame-retardants (Hansen et al., 1998; Smeets et al., 1999). Several studies 19
have demonstrated the ability of NP and BPA to inhibit androgen-induced process in 20
mammalian in vitro models (Sohoni and Sumpter, 1998; Lee et al., 2003; Xu et al., 2005). For 21
comparison purposes, we also tested in vitro the anti-androgenic of the natural oestrogen 22
oestradiol (E2).23
24
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2. Material and Methods1
2.1 Fish 2
Adult sticklebacks were caught by sand-net either in Oslo fjord (Drobak Marine Biological 3
Station) or were obtained from a supplier (Moore & Moore Carp, Reading, UK) in 2004 and 4
2005. Sticklebacks from Oslo Fjord were held in 500L tanks supplied with through-flowing 5
seawater (34‰) at 10°C at the University of Bergen. Specimens from this population were 6
used in both the in vivo and in vitro experiments. Sticklebacks from the UK supplier were 7
used for fenitrothion in vivo experiments only, and were kept in 1000L tanks supplied with 8
constant flow of Windermere lake (UK) water at ambient temperature (5-12°C) at the Centre 9
for Ecology and Hydrology (CEH, Lancaster UK).  All fish were kept under a short 10
photoperiod (8L: 16D). Earlier studies have shown that stickleback kept under this photo-11
thermal regime remain reproductively quiescent. The fish were fed daily with frozen red 12
mosquito larvae (Aleds Akvarium AB, Sweden; Tropical Marine Centre, Hertfordshire, UK). 13
Only female sticklebacks weighing more than 1g and showing no external signs of parasitic 14
infections were used. 15
16
2.2 Chemicals 17
Fenitrothion, vinclozolin, linuron, bisphenol A and nonylphenol were purchased from Qmx 18
Laboratories (Ausburg, UK). DHT, flutamide, and oestradiol were purchased from Sigma-19
Aldrich (Poole, UK). All chemicals were of analytical grade (>99% purity) and chemicals 20
with the same batch number were used in all in vitro and in vivo studies. The chemical 21
structures of the tested compounds are shown in Figure 1.22
23
2.3 In Vitro experiments24
Priming of female stickleback 25
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During previous validation of the in vitro assay using a primary culture of the stickleback 1
kidney cells, it was determined that female sticklebacks needed to be primed by DHT 2
exposure prior to tissue dissection (Jolly et al., 2006). For this, batches of females 3
sticklebacks were transferred to a 40L glass aquarium under flow-through water conditions 4
and kept under conditions of LD 12:12 photoperiod and 16°C. The androgen DHT was 5
applied to the aquarium by means of a peristaltic pump, giving a final aquarium concentration 6
of 5µg/L. A 10-day exposure to this DHT concentration resulted in an intermediate stage of 7
kidney hypertrophy in female fish, which is required for culture (Jolly et al., 2006). 8
9
Cell Dispersion10
The protocol for cell culture experiments was previously described in detail (Jolly et al., 11
2006). Briefly, DHT-primed female sticklebacks were sacrificed by destruction of the brain 12
and the kidneys quickly dissected and placed in ice-cold culture medium (M199, Gibco, 13
France). For cell dispersion, kidney tissue samples were incubated at 25°C for 15 min, in a 14
sterile solution of 0.8mg/ml porcine type II trypsin (Sigma) (prepared in Dulbecco’s saline 15
phosphate buffer without Ca2+, and Mg2+, with 100U/ml penicillin, 100µg/ml streptomycin, 16
and 250ng/ml fungizone) (Gibco). This trypsin solution was then replaced by a solution of 17
trypsin inhibitor (Sigma) and 1µg/ml DNAse (Sigma) in Dulbecco’s buffer (DB) for 10 min. 18
Kidney cells were gently dispersed in DB by repeated passages through a plastic transfer 19
pipette (Falcon). The cell suspension was filtered through nylon mesh (30 µm pore size), and 20
harvested by centrifugation at 800 rpm/min. Cells were then re-suspended in culture medium 21
(CM): medium 199 with Earle’s salts, sodium bicarbonate, 100U/ml penicillin, 100µg/ml 22
streptomycin, and 250ng/ml Fungizone (Gibco).23
24
25
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Culture system and assay procedure1
Cells were cultured in 96 well tissue culture plates (Costar) coated with Poly-L-Lysine 2
(Sigma) at a density of 125.000 cells/well. Plates were incubated at 18°C under 3% CO2 and 3
saturated humidity. After 24h of culture the medium was changed and the treatments started. 4
To determine whether any of the test chemicals possessed anti-androgenic activities in the 5
assay system, the androgen DHT was added to the culture medium at a concentration of 6
3µg/L. The ability of FL, LN, FN, VZ, E2, NP and BPA to inhibit androgen-induced spiggin 7
expression was then determined by adding a range of concentrations of the test compounds 8
[from 2.2pg/L (10-14M) to 280µg/L (10-6M)] to the DHT treated cells. The agonistic activity 9
of FL, LN, FN, VZ, E2, NP and BPA was also assessed by adding a range of concentrations 10
(2.2pg/L to 280µg/L) of the test compounds alone.11
For each test compound, a stock solution of 10mM was prepared in extra pure 96% ethanol 12
(EtOH) and stored at -20°C. For each independent assay, working solutions of the compounds 13
were prepared in culture medium on the day of use. Ethanol itself at 0.1% was applied to 14
control wells (negative control). The effect of 0.1% of ethanol was evaluated by comparison 15
to non-treated cells (medium only) in each independent experiment.16
17
Spiggin extraction and ELISA18
After 48h of incubation, cultures were stopped, the culture medium was removed and the cells 19
were washed twice with sterile PBS (Gibco). The spiggin content of the cells was extracted by 20
adding 100 µL of a denaturing buffer (100mM Tris-HCl, 10mM EDTA, 8M urea, 2% SDS 21
and 200mM β-mercaptoethanol, pH 8.5) to each well, and by sequential freezing and thawing. 22
The digests were collected and stored at -20°C until analysis. 23
24
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2.4 In vivo experiments1
In vivo experiments were performed at the University of Bergen (Norway). Adult female 2
sticklebacks were randomly selected from holding tanks. Although we took great care in 3
selecting only female fish, some misidentifications were present as it is difficult to assign sex 4
macroscopically in sticklebacks that are outside their breeding season. For this reason a total 5
of 20 fish were selected (n=20 fish/aquarium) to ensure a minimum of 15 female sticklebacks 6
per treatment. The experimental fish were transferred to 40L glass aquaria supplied with a 7
constant flow of seawater (34‰; Flow rate of 100ml/min; FL, VZ, LN) or freshwater (FN) 8
and kept under constant conditions of LD 12:12 and 15 ± 1°C. The water in all aquaria was 9
aerated constantly, and temperature, oxygen, pH and salinity monitored every two days. The 10
fish were fed daily with frozen mosquito larvae, and any accumulated waste products were 11
siphoned off every other day. The water in each individual aquarium was constantly renewed 12
(flow-through system) and chemicals were supplied by means of a microperistaltic pump 13
(Watson-Marlow, UK) at a flow rate of 100µl/min in order to keep them at a constant 14
concentration throughout the exposure time.15
16
Treatments17
All chemicals were dissolved in methanol, although the concentration of methanol in the 18
tanks never exceeded 0.01%. The effect of 0.01% of methanol itself was evaluated by 19
including a solvent control group in each independent experiment. A range of six 20
concentrations of the test compounds were co-administered with 5µg/L DHT (equivalent to 21
1.7.10-8M). The nominal concentrations chosen for FL and LN were 2, 10, 25, 75, 100, and 22
250µg/L; for FN 2, 5, 25, 60, 120, and 240µg/L; and for VZ 0.25, 2.5, 25, 100, 250, 500µg/L) 23
determined from an initial range-finding trial. In addition, each exposure experiment included 24
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a control (water only), a positive control (5µg/L DHT only), and a test compound control (test 1
compound at the highest concentration tested in the absence of DHT).2
A 21-day exposure was used, consistent with the OECD recommendations in the fish 3
screening assays for EDCs (OECD 2004). 4
5
Organ sampling6
After 21 days, the fish from all individual aquaria were terminally anesthetized in MS-222 7
(100mg/L), and snap frozen in liquid nitrogen. After weighing (±0.1g), the kidney was 8
dissected out, weighed (±0.1mg), and stored at -80°C for future spiggin analysis.  The sex of 9
each individual fish was verified macroscopically and only female fish were used in the 10
analyses (n=15 to 20).11
12
Spiggin extraction and ELISA13
200µL of denaturing buffer (as described above) was added to each kidney sample followed 14
by heating for 30min, at 70°C in order to achieve complete digestion of the tissue. The digests 15
were stored at -20°C until spiggin analysis. Spiggin level measurements were performed by 16
ELISA (Katsiadaki et al., 2002) at the Cefas Weymouth laboratory. Spiggin protein levels 17
were expressed as units of spiggin per gram of body weight.18
19
2.5 Analytical chemistry20
Water Sampling21
In order to determine the actual concentration of the test compounds, chemical analysis of the 22
tank water was performed during in vivo experiments. 1L of Water was collected from each 23
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tank every week on days 0, 7, 14 and 21. A volume of methanol equivalent to 0.1% of the 1
sample volume was added to each sample. The water samples were then filtered through 2
0,45µm sterile filters (Acorcap filter units, PN 4482, Pall life science) and SPE cartridges 3
(WAT023635, Waters Corporation, US) at a flow rate of 15ml/min. Prior to filtration, the 4
SPE cartridges were conditioned and equilibrated by gently pushing 5mL of methanol 5
followed by 5mL of distilled water. After filtration, the cartridges and filters were washed 6
with 5mL distilled water and immediately stored at -20◦C until analysis. 7
8
Sample analysis9
The cartridges were washed through with 5ml methanol in order to elute the compounds. 10
DHT was measured by radio-immunoassay (RIA) at the Cefas Weymouth laboratory 11
employing the same procedure as for other teleosts steroids (Scott et al., 1984). Briefly, the 12
methanol extracts were dried down under a stream of nitrogen gas at 45°C, reconstituted in 1 13
ml RIA buffer and stored frozen until required for assay. The recovery rate of DHT from the 14
water was tested in three separate experiments and found to lie between 60% and 65%. These 15
experiments involved “spiking” tank water samples with known amounts of DHT. Thus all 16
measured levels of DHT were multiplied by a factor of 1.6 to correct for losses that occurred17
during extraction. Radiolabelled DHT (5α-Dihydro[1,2,4,5,6,7-3H]testosterone ; product no. 18
TRK 443) was purchased from GE Healthcare, Amersham, (UK) and kept in ethanol at -19
20°C. The standard was stored in a glass container at 4°C at a concentration of 0.5mg/ml in 20
ethanol. The DHT antiserum was purchased from Biogenesis (Poole, UK, product no. 21
32500106).22
Analytical chemistry was performed at the Cefas Weymouth laboratory using liquid 23
chromatography-mass spectrometry (LC-MS) for flutamide and linuron, or gas 24
chromatography-mass spectrometry (GC-MS) for vinclozolin and fenitrothion. TBBP-A 25
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(tetrabromobisphenol A) was used as an analytical internal standard for the LC-MS analysis 1
of flutamide and linuron along the same lines as chlorobiphenyl (CB)#155 was deployed as an 2
analytical internal standard for the GC-MS analysis of vinclozolin and fenitrothion. Data 3
analysis, quantization and confirmation was achieved in Single Ion Monitoring (SIM) mode 4
using ions with m/z of, 109 and 125 for fenitrothion, 105 and 159 for vinclozolin, and 360 and 5
362 for the internal standard CB#155, and 275.1±0.5, 247.4±1.0, and 543.1±1 for flutamide, 6
linuron and TBBP-A respectively.  SIM data were collected in a retention time scheduled 7
event.8
9
2.6 Statistical analysis10
The effect of each compound was tested on two (in vivo) or three (in vitro) independent 11
experiments (performed on different fish batches and cell preparations). Figures represent the 12
results of one representative in vivo and in vitro experiment. Results are expressed as mean± 13
SEM [spiggin units/body weight (n=15) in vivo or spiggin units/well (n=6) in vitro]. Data 14
were tested for homogeneity of variance and normal distribution, and log-transformed when 15
required. A one-way ANOVA was performed followed by pairwise comparisons between test 16
and control group using a Tukey’s test.17
18
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3. Results1
2
3.1 In Vitro experiments3
3.1.1 Androgenic effects of dihydrotestosterone, flutamide, linuron, fenitrothion and 4
vinclozolin on spiggin production.5
Kidney cells treatment with a range of concentrations of DHT [10-14M (3pg/L) to 10-6M 6
(300µg/L)] alone induced spiggin production in a concentration-dependent manner (figure 2). 7
A concentration as low as 10-14M (3pg/L), induced a significant increase in spiggin cell 8
content (x1.4, P<0.05 as compared to control cell). The maximum effect was observed at the 9
highest concentration tested; 10-6M (300µg/L) DHT (x 1.7, P< 0.001 as compared to control10
cells). 11
The effects of FL, FN, LN or VZ on spiggin cell content in vitro are shown in figure 2. 12
Applied alone to kidney cells, a range of concentrations of the test compounds [from 10-14M 13
(2.5pg/L) to 10-6M (300µg/L)] had no significant effect on spiggin cell content.14
In all exposures, the solvent alone had no effect on spiggin production as compared to non-15
treated cells (medium only) (data not shown).16
17
3.1.2 Antiandrogenic effects of flutamide, fenitrothion, linuron and vinclozolin on DHT-18
induced spiggin production.19
The reference agonist, DHT, was applied at a concentration of 10-8M (3µg/L), and led to a 20
significant increase in spiggin production in the positive control cells (from x1.6 to x1.7 21
according to the cells batches, P<0.01 as compared to control cells) (figure 3). Flutamide, 22
Fenitrothion, Linuron and Vinclozolin, were able to significantly inhibit the stimulatory effect 23
of DHT in a concentration-dependent manner as shown in figure 3 (A-D).24
The inhibitory effect of flutamide is illustrated in figure 3A. Addition of 10-12M (0.28ng/L) of 25
flutamide reduced spiggin production in a significant manner (x0.82, P<0.05 as compared to 26
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positive control cells) resulting approximately in a half-maximal inhibition of the DHT 1
stimulating effect. Spiggin production was further reduced at the higher tested concentrations 2
[10-10M (28ng/L), 10-8M (2.8µg/L) and 10-6M (280µg/L)] (x0.74, and x0.73, P<0.01).3
Kidney cell treatment with 10-12M (0.28ng/L) fenitrothion significantly inhibited DHT-4
induced spiggin production (x, 0.77, P<0.05) and led to a half-maximal inhibition of the DHT 5
stimulating effect (figure 3B). The highest concentration tested [10-6M L (280µg/)] induced a 6
maximal inhibition of spiggin production (x0.65, P<0.01 as compared to positive control7
cells) resulting in a spiggin cell content similar to that of the negative control cells (x 1.06, 8
NS).9
Linuron induced a significant inhibition of spiggin production at a concentration of 10-10M 10
(25ng/L) (x 0.79, P<0.05 as compared to positive control cells) resulting in approximately 11
half-maximal reduction of the DHT-induced spiggin production (figure 3C). Furthermore, this 12
chemical caused a complete inhibition of DHT-induced spiggin production at a concentration 13
of 10-6M (250 µg/L) (x0.62, P<0.001) leading to a spiggin cell content identical to that of 14
negative control cells (x 1, NS). 15
Vinclozolin induced a decrease in spiggin cell content only at the two highest concentrations 16
tested, 10-8M (2.8µg/L) and 10-6M (280µg/L) (figure 3D). However only the highest 17
concentration [10-6M (280µg/L)] induced a spiggin cell content significantly different from 18
that of positive control cells [10-8M: x 0.89, NS; 10-6M: x 0.68, P<0.001] and resulted in a 19
spiggin cell content not significantly different from that of negative control cells (x 1.17, NS).  20
Results from the in vitro assays indicated that the four test compounds had the following 21
order of anti-androgenic potency: fenitrothion ≥ flutamide ≥ linuron > vinclozolin.22
23
3.1.3 Androgenic effects of DHT, E2, NP and BPA24
A range of concentrations of DHT [10-14M (3pg/L) to 10-6M (300µg/L)] were applied alone to 25
cultured kidney cell (figure 4). DHT induced a significant concentration-dependent increase26
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in spiggin production in vitro which was already observed at a concentration as low as 10-14M1
(3pg/L) (x1.4, P<0.05 as compared to negative control cells). The maximal effect being 2
observed at the highest concentration tested, 10-6M (300µg/L) DHT (x 1.7, P< 0.001). 3
The agonist activity of E2 was tested by adding a range of concentrations of the hormone to 4
kidney cells [from 10-14M (2.7pg/L) to 10-6M (270µg/L)] (figure 4). None of the 5
concentrations tested were able to induce a statistically significant increase in spiggin cell 6
content. Similarly, when tested alone, neither NP nor BPA were able to induce a significant 7
increase in spiggin cell content at any of the concentrations tested [from 10-14M (2.2pg/L and 8
2.3 pg/L respectively) to 10-6M (228µg/L and 220µg/L respectively)].9
10
3.1.4 Antiandrogenic effects of E2, NP and BPA11
In each individual experiment, kidney cells were treated with 10-8M (3µg/L) DHT only 12
(positive control) or with a combination of DHT (10-8M) and a range of concentrations of the 13
test compounds (figure 5). In all experiments, DHT treatment induced significant induction of 14
spiggin production by kidney cells (from x1.5 to 1.6 according to the cells batches, P< 0.001 15
as compared to negative control cells).16
E2 induced a significant but incomplete inhibition of DHT-induced spiggin production only 17
when applied at the highest concentration of 10-6M (272µg/L) (x 0.79, P<0.01 as compared to 18
positive control cells) (figure 5A). On the contrary, we observed that the two highest 19
concentrations of NP were able to significantly inhibit DHT-induced spiggin production [10-20
8M (2.2µg/L): x 0.82, P<0.01; 10-6M (220µg/L): x0.66, P<0.01 as compared to positive 21
control cells] (figure 5B). Notably, 10-6M (220µg/L) of NP induced a complete inhibition of 22
DHT-induced spiggin production resulting in spiggin cell content similar to that of the 23
negative control cells (x 1.05, NS). BPA was able to induce a significant inhibition of DHT-24
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induced spiggin production in vitro only at the highest dose tested, 10-6M (228µg/L) (x 0.83, 1
P<0.05, as compared to positive control cells) (figure 5C). 2
3
3.2 In Vivo experiments4
3.2.2 Androgenic effects of dihydrotestosterone, flutamide, linuron, fenitrothion and 5
vinclozolin on spiggin production6
The results of in vivo assays for androgenic and anti-androgenic activity of flutamide, 7
fenitrothion, linuron and vinclozolin are shown in figure 6 (A-D). In all exposures, the vehicle 8
alone (solvent controls) had no effect on spiggin production, with kidney spiggin levels 9
remaining at the basal level (101 to 102 spiggin units/g body weight, NS as compared to water 10
control) (data not shown).11
Exposure of female sticklebacks to 5µg/L DHT alone (positive control) for 21 days induced a 12
significant increase in spiggin production leading to a spiggin kidney content of 104 to 105 13
units of spiggin/g of body weight according to the different experimental fish batches (from 14
x100 to x1000 as compared to water control group; P<0.001) (figure 6 A-D). 15
Possible androgenic effects of FL, FN, LN and VZ, were assessed by applying the test 16
compounds alone at the highest concentration tested. As shown in figure 6 (A-D), none of the 17
test compounds induced spiggin production in female sticklebacks; kidney spiggin remaining 18
at the basal level (101 to 102 spiggin units/g body weight): 250µg/L FL (x 0.8, NS, as 19
compared to water control group); 250µg/L LN (x 1.2, NS); 240µg/L FN (x 0.44, NS); 20
500µg/L VZ (x 2, NS). 21
22
3.2.3 Antiandrogenic effects of flutamide, linuron, fenitrothion and vinclozolin on DHT-23
induced spiggin production24
To differing degrees, FL, FN, LN, and VZ all inhibited DHT-induced spiggin production in 25
females in a concentration-dependent manner (figure 6A-D). 26
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A 50% inhibition of spiggin production occurred approximately at 25µg/L FL (figure 6A).1
However, due to high inter-individual variability, this flutamide concentration led to a spiggin 2
level in female stickleback not significantly different from that of the positive control group 3
(x0.54, NS). Flutamide at 50µg/L induced a significant decrease in DHT-induced spiggin 4
production (x0.16, P<0.01 as compared to the positive control group). The highest 5
concentration of FL tested, 250µg/L, resulted in a complete inhibition of DHT stimulating 6
effect and spiggin production in females (x0.002, P<0.001 as compared to the positive control 7
group) leading to a spiggin kidney content not significantly different to that of the water8
control group (x 1.24, NS). 9
The effects of a range of concentrations of FN on spiggin production by DHT-stimulated 10
female stickleback are shown in figure 6B. The lowest concentration tested (1.6µg/L) induced 11
approximately 50% inhibition of DHT-induced spiggin production (x 0.46, NS as compared 12
to positive control group). At that FN concentration some female fish were highly responsive 13
while others produced spiggin. FN at 10µg/L induced a significant decrease in spiggin kidney 14
content (x0.29, P<0.01, as compared to positive control group). We observed a complete 15
inhibition of spiggin production at the highest concentration tested (240µg/L) (x 0.002, 16
P<0.001 as compared to positive control group; x 1.11, NS as compared to the water control 17
group). LN was able, significantly inhibit spiggin production content in fish exposed to DHT 18
only at the two highest concentrations tested, 100µg/L and 250µg/L (x 0.4 and x 0.08, 19
respectively, P<0.05; as compared to the positive control group) (figure 6C). None of the LN 20
concentrations tested induced complete inhibition of androgen-induced spiggin production in 21
vivo. Exposure of the fish to 100µg/L of VZ induced a significant inhibition of DHT-induced 22
spiggin production in females (x 0.016, P<0.001 as compared to the positive control group). 23
Inhibition of spiggin production was complete at the two highest VZ concentrations tested, 24
namely 250 and 500µg/L (x0.0025 and x 0.0016 respectively, P<0.001 as compared to 25
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positive control group) leading to spiggin kidney content similar to that of the water control 1
group (x 1.4, NS). 2
Results from the in vivo assays indicated that the four test compounds had the following order 3
of anti-androgenic potency: fenitrothion > flutamide ≥ vinclozolin > linuron.4
5
3.2.4 Water Chemistry6
Mean measured concentrations for chemicals (DHT, flutamide, fenitrothion, linuron and 7
vinclozolin) are presented in Table 1 (A-D). Measured concentrations of DHT as a proportion 8
of nominal concentrations (percentage of recovery) ranged from 59.5% to 100%. 9
Mean measured levels of test compounds were below the nominal values: fenitrothion (from 10
64.7% to 74%), linuron (from 30.3% to 77%), flutamide (from 27.5% to 44.7%) and lower 11
recovery rates for vinclozolin (from 6% to 11.4%).12
13
14
15
16
17
18
19
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Discussion 1
Comparison in vivo / in vitro data2
The aim of this work was, first, to assess whether kidney cell primary culture test is an 3
accurate predictor of in vivo effects of EDCs. We observed that all the compounds tested were 4
able to inhibit DHT-induced spiggin production in a concentration-dependent manner in both 5
in vivo (FN>FL≥VZ>LN) and in vitro (FN≥FL≥LN>VZ) assays. This observation 6
demonstrates that the mechanisms leading to spiggin production by androgens and inhibition 7
by anti-androgens in vivo are conserved in vitro. Previous studies demonstrated that both 8
kidney hypertrophy and spiggin production (Borg et al, 1993; Jakobsson et al., 1999) and 9
spiggin mRNA expression (Olsson et al., 2005) in vivo are androgen dependent processes. In 10
addition, we previously reported that spiggin induction by the teleost specific androgen, 11-11
ketotestosterone in vitro can be inhibited by the specific androgen receptor antagonist 12
flutamide (Jolly et al., 2006). Taken together, these data strongly suggest that spiggin 13
production by kidney cells is induced via a traditional AR-mediated pathway. Kidney cell 14
primary cultures therefore appear to be a reliable and biologically relevant screening tool to 15
predict the ability of environmental contaminants to interfere with androgen-induced 16
signalling pathways. Our present study confirms that FL as well as FN, VZ, LN, BPA and NP 17
are able to exert their anti-androgenic activity and block spiggin production via direct 18
interaction with kidney cell physiological pathways. 19
Several rapid and cost effective in vitro bioassays have been developed for the screening of 20
environmental (anti-)androgens. These cellular models are notably based either on 21
mammalian cell lines (Paris et al., 2002; Térouanne et al., 2000) or yeast strain (Sohoni and 22
Sumpter, 1998; Sanseverino et al., 2009) transfected with an androgen receptor. The overall 23
sensitivity of these assays is very good and protocols used are relatively standardized and 24
miniaturised. However cell transfection with receptor-reporter system may introduce 25
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variations that can lead to contradictory observations according to the bioassays selected. In 1
addition, other parameters of the cellular environment, such as the presence of co-activators or 2
co-repressors of AR transactivation, can significantly influence the (anti-)androgenic 3
potencies of both natural hormones and xenobiotics (Simon and Mueller, 2006). For these 4
reasons extrapolation from data obtained in heterologous/artificial models to responses 5
elicited in vivo appears difficult. As natural targets of steroid hormones, stickleback kidney 6
cells constitute a particularly powerful model to further investigate the molecular and cellular 7
mechanisms by which man-made environmental contaminants exert their (anti-)androgenic 8
effects. 9
In general, rapid and cost-effective in vitro assays are particularly suitable for primary 10
screening experiments. Indeed, as compared to in vivo studies, in vitro systems use fewer11
experimental fish and they permit a significant reduction in the amount of harmful chemicals 12
needing to be used. For example in the present study approximately 600 fish were sacrificed 13
to test the anti-androgenic properties of six chemicals in vivo (five concentrations), while 50 14
fish only were needed to screen the same number of compounds in vitro (fives 15
concentrations). This is of paramount importance in view of the thousand of man-made 16
chemicals that are produced and released in the environment every year. Of particular concern 17
are those chemicals possessing structural similarities to pharmaceutical anti-androgen 18
flutamide, i.e. a phenol-ring (see figure 1), which appears to be a common feature of the 19
natural or man-made compounds that are able to bind steroid hormone receptors. Based on 20
this observation one can predict that a significant number of other chemicals, such as the 21
insecticide parathion (Sohoni et al., 2001), or the herbicide diuron (Bauer et al., 1998) could 22
potentially act as (anti-)androgens. 23
The complexity of endocrine function in animals makes it difficult to rely on in vitro data 24
alone to predict the endocrine disrupting properties of man-made chemicals in general. The 25
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use of the stickleback as model organism allows the development of comparative in vivo/in 1
vitro studies for the first time in teleosts. This is particularly important to further understand 2
transmission of the adverse effects that occur at the molecular and cellular levels at the 3
organism and population level.4
Analytical chemistry data showed that only low percentages of the nominal concentrations of 5
flutamide and vinclozolin could be measured in the water (Table 1A and 1D). The reasons for 6
such low recovery rates have not been clarified yet. However, comparable results were 7
reported by Allen and co-workers (2008) in a stickleback intercalibrating in vivo study. Taken 8
together these observations suggest that the true lowest observed effects values in the 9
stickleback are potentially lower than those reported so far.  10
11
Comparison of stickleback versus mammalian models12
Several studies reported that teleosts unlike mammals possess two AR (alpha and beta) 13
subtypes that differ in their binding affinities for endogenous hormones and tissue distribution 14
(Takeo and Yamashita, 1999; Todo et al, 1999; Ikeuchi et al, 1999). In the stickleback, an 15
androgen receptor (ARβ) has been cloned from kidney mRNA and the molecular structure of 16
the two splicing variants has been characterized (termed AR1 and AR2) (Olsson et al, 17
2005). These two variants show high similarities with the mammalian androgen receptor. 18
Consistent with this finding we report a clear correlation between mammalian and stickleback 19
in vivo and in vitro response to flutamide, fenitrothion, linuron and vinclozolin (summarized 20
in Table 2A and 2B). 21
For example, Sohoni et al. (2001) showed that fenitrothion is able to antagonize the 22
androgenic effect of DHT in recombinant yeast expressing the human receptor. Similarly, 23
Tamura and co-workers (2001) reported that the potency of fenitrothion as a competitive AR 24
antagonist was comparable to that of flutamide in human cell line transfected with the human 25
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AR as well as in the Hershberger assay. In the present study, fenitrothion was the most 1
efficient chemical at inhibiting DHT-induced spiggin synthesis in vivo and appeared to 2
possess a potency comparable to that of flutamide in vitro. Indeed, both chemicals induced a 3
significant decrease in spiggin cell content at a concentration as low as 10-12M (2.8ng/L). We 4
observed that in vivo fenitrothion significantly inhibited spiggin production at a nominal 5
concentration as low as 10µg/L while flutamide and linuron were effective at 25µg/L and 6
100µg/L respectively. The ability of linuron to inhibit the binding of androgens to rat prostatic 7
AR was reported in early competitive receptor binding studies (Cook et al., 1993; Bauer et 8
al., 1998). Later Lambright et al. (2000) showed that linuron also has affinity for the human 9
AR, using a transfected COS cell line assay, and that it induces a decrease in the weight of 10
DHT-dependent tissues in the Hershberger assay.  McIntyre et al, (2000) also observed that in 11
utero exposure to linuron impairs androgen-mediated reproductive development in male rat. 12
In the same study, the authors showed that in hepatoma cell line transfected with human AR 13
linuron competitively antagonize AR DHT-induced transcriptional activity in a concentration-14
dependent manner. In the present study, linuron inhibited DHT-induced spiggin production in 15
vivo and in vitro at a concentration of 100µg/L (nominal concentration) and 10-10M (25ng/L),16
respectively. Linuron appeared to be the least potent of the chemicals tested in vivo while in 17
vitro it appeared more potent than vinclozolin which induced a significant decrease in spiggin 18
production only at the highest concentration tested (10-6M or 280µg/L). In vivo, 100µg/L of 19
vinclozolin (nominal concentration) proved to be sufficient to inhibit spiggin production in 20
DHT-treated female sticklebacks. Gray and co-workers, (1994) reported for the first time the 21
ability of this pesticide to inhibit sexual differentiation in an anti-androgenic manner in male 22
rats. 23
It has been demonstrated that vinclozolin itself is a weak AR antagonist and that its anti-24
androgenic effects is mediated mainly via its two main degradation products, M1 and M2 25
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(Kelce et al., 1994). Wong et al., (1995) demonstrated that M1 and M2, are potent AR 1
antagonists that are able to inhibit AR binding to androgen response element (ARE) sequence, 2
thus inhibiting the transcription of AR-dependent genes in human cell line transfected with a 3
recombinant human AR. In the present study, vinclozolin appeared as a weak anti-androgen 4
in vitro. 5
6
Comparison of stickleback versus other teleost models7
In addition to the stickleback, a number of teleosts are now promoted as model species in 8
laboratory experiments to assess the adverse effect of man-made EDCs on aquatic wildlife. 9
We observed a good correlation between our data and some of the results reported in the 10
literature. For example exposure of juvenile guppies to vinclozolin or flutamide resulted in a 11
reduction in the expression of male secondary sex characters, a reduced sperm count and 12
finally skewed sex ratio towards female (Bayley et al., 2002) and high vinclozolin 13
concentration (2500μg/L) affected spermatogenesis in male Japanese medaka (Oryzias 14
latipes) (Kiparissis et al., 2003). Panter and co-workers (2003 and 2004) reported that both 15
flutamide and vinclozolin are able to block androgen induced processes in adult fish using a 16
fathead minnow (Pimephales promelas) non-spawning assay. On the contrary, Makynen and 17
colleagues (2000) reported that fathead minnow exposed to high concentrations of vinclozolin 18
(90-1200µg/L) for 34 days through early embryonic and larval life stages developed normally 19
in terms of growth and sexual differentiation. The authors also investigated through 20
competitive radioligand binding experiments the affinity of vinclozolin and its metabolites for 21
the fathead minnow androgen receptor and observed that neither vinclozolin nor M1 or M2 22
could compete for testosterone binding sites. Similarly, Wells and Van der Kraak (2000) 23
reported that neither flutamide nor vinclozolin and its metabolistes possess affinity to ARs 24
from the goldfish (Crassius auratus) or the rainbow trout (Oncorhyncus mykiss). 25
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It is likely that some of the discrepancies we report above and which are summarized in Table 1
2A and 2B, result from differences in the methodologies used to assess the endocrine activity2
of the test chemicals. However, the existence of significant differences in the regulation of the 3
endocrine function among teleosts such as the occurrence of different AR subtypes with 4
different affinities for both endogenous hormones and endocrine disrupting compounds5
cannot be ruled out. These differences should be accounted for especially when promoting 6
new bio-indicator species. Our results suggest that the stickleback is potentially a suitable 7
model to study the impact of EDCs on androgen mediated pathways in humans.8
9
Oestrogens act as anti-androgens in stickleback kidney cell primary culture 10
After validation of our in vitro model with known anti-androgens we applied our assay to the 11
screening of the natural steroid, E2 and two estrogenic environmental chemicals (NP and 12
BPA) that are able to interfere with the functioning of AR in mammals (Sohoni and Sumpter, 13
1998; Lee et al., 2003; Xu et al., 2005). Inhibition of DHT-induced spiggin production in 14
vitro was observed at the highest concentrations tested only for all the three chemicals [i.e. E2: 15
10-6M (270µg/L); NP: 10-8 and 10-6M (2.2 and 220µg/L); BPA: 10-8 and 10-6M (2.3 and 16
230µg/L)]. Oguro (1957) reported for the first time the ability of E2 to induce a regression of 17
kidney hypertrophy in the stickleback in vivo. In the present study, we demonstrate the ability 18
of E2 to exert its anti-androgenic effect via direct interaction with kidney cells. The molecular 19
mechanisms by which E2 is able to interfere with spiggin production in vitro remain to be 20
identified. Gaido et al., (1997) showed E2 to be about 1/30
th the potency of DHT to bind the 21
human AR, while Olsson and co-workers (2005) reported that E2 is able to down regulate the 22
expression of AR mRNA in the stickleback in vivo. These data suggest that E2 is able to exert 23
its anti-androgenic effect by interfering directly with AR expression and/or activity. However 24
the steroid response in animals is highly complex and can include cross talk among steroids 25
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and steroids receptors. Therefore we cannot exclude that E2 anti-androgenic effects involve 1
receptors other than the AR. 2
Similarly, for the first time in teleosts, we report the anti-androgenic properties of two 3
oestrogenic endocrine-disrupting compounds: BPA and NP. To our knowledge, the anti-4
androgenic properties of NP and BPA have been reported only in a recombinant in vitro5
system, using assays based on mammalian cell lines or yeast strain transfected with 6
mammalian AR (Sohoni and Sumpter, 1998; Lee et al., 2003; Xu et al., 2005). Notably, 7
Sohoni and Sumpter (1998) reported that BPA is able to antagonise androgens at 8
concentrations above 10-6M (228µg/L) in a yeast-based assay transfected with the human AR. 9
Later, Lee et al., (2003) showed that BPA and NP have anti-androgenic activity at multiple 10
steps of mouse AR activation and function in vitro. Both compounds were able to inhibit AR 11
androgen binding, AR nuclear import and its subsequent trans-activation in a concentration-12
dependent manner. As for E2, the molecular mechanisms involved in inhibition of androgen-13
induced spiggin production by BPA and NP in vitro remain to be clarified. 14
We have previously reported the anti-androgenic effect of ethinyl-oestradiol in an identical in 15
vivo system (Katsiadaki et al., 2006) and we are currently analysing the data from in vivo 16
exposures employing BPA, NP and E2. Preliminary data suggest that the anti-androgenic 17
effect of E2 is apparent at lower concentrations than those detected by our in vitro system. 18
Therefore our future in vivo/in vitro studies will aim at further deciphering the anti-19
androgenic properties and the mechanism of action of xenoestrogens in the stickleback. 20
21
Conclusion22
The present study offers further validation of the in vitro kidney cell assay we have 23
developed. Most importantly, we present here the first attempt to develop an integrated in 24
vivo/in vitro screening strategy for assessing the effects of (anti-)androgenic environmental 25
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contaminants. These combined in vivo/in vitro assays are particularly needed to further 1
understand the transmission at the organism and population level of adverse effects that occur 2
at the molecular and cellular levels. In particular future studies will investigate the molecular 3
mechanisms involved in inhibition of spiggin production by vinclozolin, linuron, fenitrothion, 4
bisphenol A, nonylphenol and oestradiol in the three-spined stickleback. 5
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Figure legend1
Figure 1.2
Structural formulae of flutamide, fenitrothion, linuron, vinclozolin, nonylphenol and 3
bisphenol A. 4
5
Figure 2.6
Concentration-response curves of spiggin induction obtained with androgen-primed females 7
kidney cells treated for 48h with solvent only (control) or a range of DHT concentrations (-○-) 8
[from 10-14M (3pg/L) to 10-6M (300µg/L)], or Fenitrothion (-♦-), Flutamide (-*-), Vinclozolin 9
(-■-) [from 10-14M (2.8 pg/L) to 10-6M (280µg/L)] and Linuron (-Δ-) [from 10-14M (2.5pg/L)10
to 10-6M (250µg/L)]. Means ± SEM (n=6) are given. Figure displays the results of one 11
representative experiment from three independent experiments.12
13
Figure 3.14
Effect of flutamide (A), fenitrothion (B), linuron (C) and vinclozolin (D) on DHT-induced 15
spiggin production by female kidney cells treated for 48h.16
Diagonally hatched and grey columns show cells treated with DHT [10-8M (3µg/L)] together 17
with a range of concentrations of flutamide, fenitrothion and vinclozolin [from 10-14M 18
(2.8pg/L) to 10-6M (280µg/L)] or linuron [from 10-14M (2.5pg/L) to 10-6M (250µg/L)]. 19
Solvent control (open column): cells exposed to solvent only; Positive control (black column): 20
cells treated with 10-8M DHT (3µg/L) only. Mean values are given ± SEM shown. (n=6).21
Asterisks indicate groups that were significantly different from the positive control. Figure 22
displays one representative experiment from three independent experiments.23
24
Figure 4.25
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Concentration-response curves of spiggin induction obtained with androgen-primed kidney 1
cells of females treated for 48h with solvent only (control) or a range of DHT concentrations 2
(--) [from 10-14M (3pg/L) to 10-6M (300µg/L)], or oestradiol (-*-) [from 10
-14M (2.7pg/L) to 3
10-6M (270µg/L)], nonylphenol (-°-) [from 10
-14M (2.2pg/L) to 10-6M (200µg/L)], and 4
bisphenol A (-♦-) [from 10-14M (2.3pg/L) to 10-6M (230µg/L)]. Means ± SEM (n=6) are 5
given. Figure displays the results of one representative experiment from three independent 6
experiments.7
8
9
Figure 5.10
Effects of oestradiol (A), nonylphenol (B), and bisphenol A (C) on DHT-induced spiggin 11
production by female kidney cells treated for 48h.12
Diagonally hatched and grey columns show cells treated with 10-8M DHT (3µg/L) together 13
with a range of oestradiol concentrations [from 10-14M (2.7pg/L) to 10-6M (270µg/L)], 14
nonylphenol [from 10-14M (2.2pg/L) to 10-6M (220µg/L)] or bisphenol A [from 10-14M 15
(2.3pg/L) to 10-6M (230µg/L)]. Solvent control (open column): cells exposed to solvent only; 16
Positive control (black column): cells treated with 10-8M DHT (3µg/L) only. Mean values are 17
given ± SEM shown. (n=6). Asterisks indicate groups that were significantly different from 18
the positive control. Figure displays one representative experiment from three independent 19
experiments.20
21
22
23
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Figure 6.1
Effect of flutamide (A), linuron (B), fenitrothion (C) and vinclozolin (D), on spiggin 2
production by DHT-stimulated females, during 21 days in vivo exposure. Diagonally hatched 3
columns show a range of concentrations of the respective test compounds administered 4
together with DHT (5 µg/L). Solvent control (open column): fish exposed to solvent only; 5
Positive control (black column): treated with 5µg/L DHT only. Negative control (grey 6
column): addition of the test compound alone, at the highest concentration used. Asterisks 7
indicate groups that were significantly different from the positive control. Mean values are 8
given ± SEM. (n=15 fish/tank).9
10
Table 1 (A-D)11
Measured and nominal concentrations of DHT and FL (A), FN (B), LN (C), and VZ (D) from 12
each treatment. Values are the mean of four sampling occasions (days 0, 7, 14 and 21) during 13
the exposure period. Concentrations are expressed as μg/L. nd= non detectable. 14
15
Table 2 (A and B) 16
Summarized results of androgenic and anti-androgenic activities of different chemicals in 17
vivo (A) and in vitro (B).  = agonist activity; =antagonist activity; (-) = no effect; nd =no 18
data available.19
Page 41 of 50
Ac
ce
pte
d M
an
us
cri
pt
Table 1-A 
Nominal 0 250 0 5 25 50 75 100 250
Flutamide Measured (mean) n.d. 69,0 n.d. 2,1 10,2 22,3 32,3 41,3 96,3
sem - 18,0 - 0,2 0,4 2,6 3,5 3,3 5,4
% recovery 27,6 42,7 40,8 44,7 43,1 41,3 38,5
Nominal 0,0 0,0 5,0 5,0 5,0 5,0 5,0 5,0 5,0
DHT Measured (mean) n.d. n.d. 4,2 3,8 3,2 3,6 3,5 3,8 3,0
sem - - 0,4 0,5 0,2 0,4 0,6 0,4 0,1
% recovery 83,1 76,9 64,6 71,8 69,7 76,9 59,5
Table 1-B 
Nominal 0 240 0 2 10 25 60 120 240
Fenitrothion Measured (mean) n.d. 174,2 n.d. 1,1 6,5 16,8 41,2 88,0 177,6
sem - 9,0 - 0,0 0,3 0,6 1,4 2,5 7,2
% recovery 72,6 70,6 64,7 67,1 68,7 73,3 74,0
Nominal 0,0 0,0 5,0 5,0 5,0 5,0 5,0 5,0 5,0
DHT Measured (mean) n.d. n.d. 4,9 4,9 5,1 4,3 5,1 4,5 3,9
sem - - 0,3 0,3 0,2 0,2 0,3 0,4 0,3
% recovery 97,2 98,5 102,2 86,8 102,2 89,8 78,8
Table(s)
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Table 1-C
Nominal 0 250 0 3 10 25 100 250
Linuron Measured (mean) n.d. 121,5 n.d. 1,0 4,8 7,6 58,0 193,3
sem - 5,1 - 0,1 - 0,3 11,8 14,5
% recovery 48,6 40,0 47,5 30,3 58,0 77,3
Nominal 0,0 0,0 5,0 5,0 5,0 5,0 5,0 5,0
DHT Measured (mean) n.d. n.d. 3,8 3,9 4,3 3,6 5,0 4,0
sem - - 0,3 0,4 - 0,2 0,7 0,2
% recovery 76,2 77,6 86,2 71,6 100,0 80,0
Table 1-D 
Nominal 0 500 0 0 3 25 100 250 500
Vinclozolin Measured (mean) n.d. 48,0 n.d. n.d. n.d. 2,0 11,4 15,1 41,5
sem - 6,2 - - - 0,5 5,1 3,1 5,8
% recovery 9,6 7,9 11,4 6,0 8,3
Nominal 0,0 0,0 5,0 5,0 5,0 5,0 5,0 5,0 5,0
DHT Measured (mean) n.d. n.d. 4,3 4,9 4,5 4,4 4,1 4,9 4,5
sem - - 0,2 0,4 0,2 0,5 0,7 0,6 0,7
% recovery 86,4 97,0 90,0 87,6 82,0 98,4 89,2
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Table 2-A Stickleback Medaka Guppy fathead minnow rodent  human 
 (Gasterosteus aculeatus) (Orysias latipes) (Poecilia reticulata) (Pimephales promelas)    
 
    (1)Kang et al, 2004  
     (2)Tamura et al., 2001  
 (1)Oguro, 1957 Kiparissis et al., 2003 Bayley et al., 2002 (1)Panter et al., 2004 (3)Kelce et al., 1994 McLeod et al., 1993 
    (2)Makynen et al., 2000 (4)Lambright et al., 2000 McLeod, 1993 
 
   
 (5)McIntyre et al., 2000  
     (6)Sohoni et al., 2001  
          (7) Sunami et al., 2000   
     
  
 
Fenitrothion  nd nd nd        (2)/-(6,7) nd 
Flutamide  nd  (1)  (1)  
Vinclozolin    -/(2)   (1,3) nd 
Linuron  nd nd nd      (1,4,5) nd 
Oestradiol 
   
(1)
 nd nd nd nd  
Nonylphenol nd nd nd - nd nd 
Bisphenol A nd nd nd nd nd nd 
 
Table(s)
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Table 2-B Stickleback Goldfish Rainbow trout fathead minnow rodent  human 
 (Gasterosteus aculeatus) (Carassius auratus) (Oncorhynchus mykiss) (Pimephales promelas)    
 
    
  (1)Sohoni et al., 2001 
     (1)Monosson et al., 1999 (2)Wong et al., 1995 
     (2)Cook et al., 1993 (3)Lambright et al., 2000 
  
                     Wells & Van der Kraak, 2000 Makynen et al., 2000  (3)Bauer et al., 1998 (4)Sohoni & Sumpter, 1998 
      (4)Lee et al., 2003 (5) Paris et al., 2002 
  
   
  (6)Sultan et al., 2001  
  
   
  (7)Tamura et al., 2001 
          
 (8) Gaido et al., 1997 
 
    
 
Fenitrothion  nd nd nd nd (1,7) / (1) 
Flutamide  - - nd nd (2,4) 
Vinclozolin  - - -    (1) (2,4) / (4) 
Linuron  nd nd nd      (2,3) (3) 
Oestradiol  nd nd nd nd (8,4) 
Nonylphenol  nd nd nd (4) (6) / (4) 
Bisphenol A  nd nd nd (4) (4,5,6) 
 
Table(s)
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Fig.1
Fenitrothion
Flutamide
Linuron
Bisphenol A
Nonylphenol
Vinclozolin
Figures
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Fig.3 
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Fig. 5
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